HX016-9

N/A

Report date: 2025/07/07 16:04:48

Base Information

Drug NameHX016-9
Drug Alias NameHX016-9
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionProgrammed cell death protein 1 inhibitorsVascular endothelial growth factor inhibitors
TargetsProgrammed cell death protein 1Vascular endothelial growth factor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHanx Biopharmaceuticals (Wuhan) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHanx Biopharmaceuticals (Wuhan) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A